Literature DB >> 33673701

Controlling Ratios of Plasmid-Based Double Cut Donor and CRISPR/Cas9 Components to Enhance Targeted Integration of Transgenes in Chinese Hamster Ovary Cells.

Sung Wook Shin1, Dongwoo Kim1, Jae Seong Lee1.   

Abstract

Chinese hamster ovary (CHO) cells are the most valuable expression host for the commercial production of biotherapeutics. Recent trends in recombinant CHO cell-line development have focused on the site-specific integration of transgenes encoding recombinant proteins over random integration. However, the low efficiency of homology-directed repair upon transfection of Cas9, single-guide RNA (sgRNA), and the donor template has limited its feasibility. Previously, we demonstrated that a double-cut donor (DCD) system enables highly efficient CRISPR/Cas9-mediated targeted integration (TI) in CHO cells. Here, we describe several CRISPR/Cas9 vector systems based on DCD templates using a promoter trap-based TI monitoring cell line. Among them, a multi-component (MC) system consisting of an sgRNA/DCD vector and Cas9 expression vector showed an approximate 1.5-fold increase in knock-in (KI) efficiency compared to the previous DCD system, when a systematically optimized relative ratio of sgRNA/DCD and Cas9 vector was applied. Our optimization efforts revealed that concurrently increasing sgRNA and DCD components relative to Cas9 correlated positively with KI efficiency at a single KI site. Furthermore, we explored component bottlenecks, such as effects of sgRNA components and applicability of the MC system on simultaneous double KI. Taken together, we improved the DCD vector design by tailoring plasmid constructs and relative component ratios, and this system can be widely used in the TI strategy of transgenes, particularly in CHO cell line development and engineering.

Entities:  

Keywords:  CRISPR/Cas9; Chinese hamster ovary (CHO); Double cut donor; Homology-directed repair; Multiple knock-in; Targeted integration; Vector construction

Mesh:

Substances:

Year:  2021        PMID: 33673701      PMCID: PMC7957797          DOI: 10.3390/ijms22052407

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  30 in total

1.  Sequence requirements for plasmid nuclear import.

Authors:  D A Dean; B S Dean; S Muller; L C Smith
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

2.  A regulated, NFkappaB-assisted import of plasmid DNA into mammalian cell nuclei.

Authors:  A Mesika; I Grigoreva; M Zohar; Z Reich
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

3.  Minimizing Clonal Variation during Mammalian Cell Line Engineering for Improved Systems Biology Data Generation.

Authors:  Lise Marie Grav; Daria Sergeeva; Jae Seong Lee; Igor Marin de Mas; Nathan E Lewis; Mikael Rørdam Andersen; Lars Keld Nielsen; Gyun Min Lee; Helene Faustrup Kildegaard
Journal:  ACS Synth Biol       Date:  2018-08-16       Impact factor: 5.110

4.  Accelerated homology-directed targeted integration of transgenes in Chinese hamster ovary cells via CRISPR/Cas9 and fluorescent enrichment.

Authors:  Jae Seong Lee; Lise Marie Grav; Lasse Ebdrup Pedersen; Gyun Min Lee; Helene Faustrup Kildegaard
Journal:  Biotechnol Bioeng       Date:  2016-06-03       Impact factor: 4.530

5.  A role for alternative end-joining factors in homologous recombination and genome editing in Chinese hamster ovary cells.

Authors:  Sandra Bosshard; Pierre-Olivier Duroy; Nicolas Mermod
Journal:  DNA Repair (Amst)       Date:  2019-08-15

6.  Optimized CRISPR/Cas9 strategy for homology-directed multiple targeted integration of transgenes in CHO cells.

Authors:  Sung Wook Shin; Jae Seong Lee
Journal:  Biotechnol Bioeng       Date:  2020-03-02       Impact factor: 4.530

7.  p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.

Authors:  Robert J Ihry; Kathleen A Worringer; Max R Salick; Elizabeth Frias; Daniel Ho; Kraig Theriault; Sravya Kommineni; Julie Chen; Marie Sondey; Chaoyang Ye; Ranjit Randhawa; Tripti Kulkarni; Zinger Yang; Gregory McAllister; Carsten Russ; John Reece-Hoyes; William Forrester; Gregory R Hoffman; Ricardo Dolmetsch; Ajamete Kaykas
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

8.  Nuclear domain 'knock-in' screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing.

Authors:  Jordan Pinder; Jayme Salsman; Graham Dellaire
Journal:  Nucleic Acids Res       Date:  2015-10-01       Impact factor: 16.971

9.  Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks.

Authors:  Fei Song; Knut Stieger
Journal:  Mol Ther Nucleic Acids       Date:  2017-02-28

10.  CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos.

Authors:  Evguenia Kouranova; Kevin Forbes; Guojun Zhao; Joe Warren; Angela Bartels; Yumei Wu; Xiaoxia Cui
Journal:  Hum Gene Ther       Date:  2016-05-12       Impact factor: 5.695

View more
  1 in total

Review 1.  Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells.

Authors:  Mian Wei; Chun-Liu Mi; Chang-Qin Jing; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.